Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Keating

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Insight (American Society of Ophthalmic Registered Nurses)|May 23, 2014
Nurses' Health Study: landmark study recruiting for third cohortMichael Keating
Mayo Clinic Women'S Healthsource|September 6, 2005
Mayo Clinic office visit. Germs and you. An interview with Michael Keating, M.DMichael Keating
Anesthesiology Clinics of North America|June 1, 2005
Preoperative evaluation and methods to reduce blood use in orthopedic surgeryE Michael Keating
Medical Oncology (Northwood, London, England)|August 16, 2002
Alemtuzumab, the first monoclonal antibody (MAb) directed against CD52Michael Keating, Michael Hallek
The Journal of Arthroplasty|December 13, 2002
Perioperative blood salvage as an alternative to predonating blood for primary total knee and hip arthroplastyE Michael Keating, Merrill A Ritter
The Journal of the American Academy of Orthopaedic Surgeons|December 10, 2002
Perioperative blood management practices in elective orthopaedic surgeryE Michael Keating, John B Meding
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|June 30, 2018
Multifocal Soft Tissue Cryptococcosis in a Renal Transplant Recipient: The Importance of Suspecting Atypical Pathogens in the Immunocompromised HostSaira Ajmal, Michael Keating, Mark Wilhelm
Medical Oncology (Northwood, London, England)|August 16, 2002
Clinical effects of alemtuzumab (Campath-1H) in B-cell chronic lymphocytic leukemiaAnders Osterborg, Hakan Mellstedt, Michael Keating
Leukemia & Lymphoma|December 29, 2012
The significance of spliceosome mutations in chronic lymphocytic leukemiaUri Rozovski, Michael Keating, Zeev Estrov
The Journal of Arthroplasty|June 18, 2002
Transfusion options in total joint arthroplastyE Michael Keating, Merrill A Ritter
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Insight (American Society of Ophthalmic Registered Nurses)|May 23, 2014
Nurses' Health Study: landmark study recruiting for third cohortMichael Keating
Mayo Clinic Women'S Healthsource|September 6, 2005
Mayo Clinic office visit. Germs and you. An interview with Michael Keating, M.DMichael Keating
Anesthesiology Clinics of North America|June 1, 2005
Preoperative evaluation and methods to reduce blood use in orthopedic surgeryE Michael Keating
Medical Oncology (Northwood, London, England)|August 16, 2002
Alemtuzumab, the first monoclonal antibody (MAb) directed against CD52Michael Keating, Michael Hallek
The Journal of Arthroplasty|December 13, 2002
Perioperative blood salvage as an alternative to predonating blood for primary total knee and hip arthroplastyE Michael Keating, Merrill A Ritter
The Journal of the American Academy of Orthopaedic Surgeons|December 10, 2002
Perioperative blood management practices in elective orthopaedic surgeryE Michael Keating, John B Meding
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|June 30, 2018
Multifocal Soft Tissue Cryptococcosis in a Renal Transplant Recipient: The Importance of Suspecting Atypical Pathogens in the Immunocompromised HostSaira Ajmal, Michael Keating, Mark Wilhelm
Medical Oncology (Northwood, London, England)|August 16, 2002
Clinical effects of alemtuzumab (Campath-1H) in B-cell chronic lymphocytic leukemiaAnders Osterborg, Hakan Mellstedt, Michael Keating
Leukemia & Lymphoma|December 29, 2012
The significance of spliceosome mutations in chronic lymphocytic leukemiaUri Rozovski, Michael Keating, Zeev Estrov
The Journal of Arthroplasty|June 18, 2002
Transfusion options in total joint arthroplastyE Michael Keating, Merrill A Ritter
Pageof 19